Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 13/20 | 0.62 |
| ▸ | SLC6A4 | P31645 | 12/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.62 |
| ▸ | DPP4 | P27487 | 1/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3405893 | 0.81 | SLC6A3 (0.62) | SLC6A3SLC6A4SLC6A2DPP4MAOA | |
| SCHEMBL11481504 | 0.77 | SLC6A3 (0.57) | SLC6A3SLC6A4SLC6A2DPP4MAOA | |
| SCHEMBL31116706 | 0.77 | SLC6A3 (0.57) | SLC6A3SLC6A4SLC6A2DPP4MAOA | |
| SCHEMBL17666846 | 0.77 | MEN1 (0.41) | SLC6A3SLC6A4SLC6A2DPP4 | |
| SCHEMBL3517653 | 0.77 | SLC6A3 (1.00) | SLC6A3SLC6A4SLC6A2DPP4 | |
| SCHEMBL6184366 | 0.75 | SLC6A3 (0.59) | SLC6A3SLC6A4SLC6A2DPP4 | |
| SCHEMBL17666847 | 0.74 | MEN1 (0.39) | SLC6A3SLC6A4SLC6A2DPP4 | |
| Hydrochloric Acid SCHEMBL6185182 | 0.74 | SLC6A3 (0.58) | SLC6A3SLC6A4SLC6A2DPP4 | |
| SCHEMBL294761 | 0.74 | DPP4 (0.96) | SLC6A3SLC6A4SLC6A2DPP4MAOA | |
| SCHEMBL19617106 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040063643-A1 | Bombesin antagonists | PFIZER INC. | 2004-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063643-A1 | Bombesin antagonists | BRS3, NPSR1, GNRHR | SLC6A3 465/4885SLC6A4 419/4885SLC6A2 256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.